Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Rizatriptan 10mg tablets

Active Ingredient:
rizatriptan benzoate
Company:  
Aspire Pharma Ltd See contact details
ATC code: 
N02CC04
{info_black}
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 19 Jun 2023

Below is a text only representation of the Patient Information Leaflet (ePIL).

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on {phone} 0800 198 5000. The product code(s) for this leaflet is: PL35533/0005.

Rizatriptan 5mg and 10mg tablets

Package Leaflet: Information for the User

Rizatriptan 5mg tablets

Rizatriptan 10mg tablets

rizatriptan

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4

What is in this leaflet:

1. What this medicine is and what it is used for
2. What you need to know before you take this medicine
3. How to take this medicine
4. Possible side effects
5. How to store this medicine
6. Contents of the pack and other information

1. What this medicine is and what it is used for

Rizatriptan belongs to a class of medicines called selective serotonin 5-HT1B/1D receptor agonists.

This medicine is used to treat the headache phase of a migraine attack in adults.

Treatment with this medicine reduces swelling of blood vessels surrounding the brain. This swelling results in the headache pain of a migraine attack.

2. What you need to know before you take this medicine
Do not take this medicine if:
  • you are allergic to rizatriptan benzoate or any of the other ingredients of this medicine (listed in Section 6)
  • you have moderately severe or severe high blood pressure, or mild high blood pressure that is not controlled by medicine
  • you have or have ever had heart problems including heart attack or pain in the chest (angina) or you have experienced heart disease related signs
  • you have severe liver or severe kidney problems
  • you have had a stroke (cerebrovascular accident, CVA) or mini stroke (transient ischaemic attack, TIA)
  • you have blockage problems with your arteries (peripheral vascular disease)
  • you are taking monoamine oxidase (MAO) inhibitors such as moclobemide, phenelzine, tranylcypromine, or pargyline (medicines against depression), linezolid (an antibiotic) or if it has been less than two weeks since you stopped taking MAO inhibitors
  • you are taking ergotamine-type medicines, such as ergotamine or dihydro-ergotamine to treat your migraine or methysergide to prevent a migraine attack
  • you are taking any other medicine in the same class, such as sumatriptan, naratriptan or zolmitriptan to treat your migraine (see other medicines and rizatriptan below)

If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking this medicine.

Warnings and precautions

Talk to your doctor or pharmacist before taking this medicine if:

  • you have any of the following risk factors for heart disease: high blood pressure, diabetes, you smoke or you are using nicotine substitution, your family has a history of heart disease, you are a man over 40 years of age, or you are a post-menopausal woman
  • you have kidney or liver problems
  • you have a particular problem with the way your heart beats (bundle branch block)
  • you have or have had any allergies
  • you have headaches associated with dizziness, difficulty in walking, lack of co-ordination or weakness in the leg and arm
  • you use any herbal preparation containing St. John’s Wort
  • you have had an allergic reaction involving swelling of the face, lips, tongue and/or throat which may cause difficulty breathing and/or swallowing (angioedema)
  • you are taking selective serotonin reuptake inhibitors (SSRIs) such as sertraline, escitalopram oxalate and fluoxetine, or serotonin norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine, or duloxetine for depression
  • you have had short lived symptoms including chest pain and tightness

If you take rizatriptan too often, you may get a chronic headache.

In such cases you should contact your doctor as you may have to stop taking this medicine.

Tell your doctor or pharmacist about your symptoms. Your doctor will decide if you have a migraine. You should take this medicine only for a migraine attack. This medicine should not be used to treat headaches that might be caused by other, more serious conditions.

Other medicines and rizatriptan

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This includes herbal medicines and those you normally take for a migraine. This is because rizatriptan can affect the way some medicines work. Also, other medicines can affect this medicine.

Do not take this medicine if you are taking:
  • a 5-HT1B/1D agonist (sometimes referred to as ‘triptans’), such as sumatriptan, naratriptan or zolmitriptan
  • a monoamine oxidase (MAO) inhibitor such as moclobemide, phenelzine, tranylcypromine, linezolid, or pargyline, or if it has been less than two weeks since you stopped taking a MAO inhibitor
  • ergotamine-type medicines such as ergotamine or dihydro-ergotamine to treat your migraine
  • methysergide to prevent a migraine attack

The above listed medicines when taken with rizatriptan may increase the risk of side effects.

You should wait at least 6 hours after taking this medicine before you take ergotamine-type medicines such as ergotamine or dihydro-ergotamine or methysergide.

You should wait at least 24 hours after taking ergotamine-type medicines before taking this medicine.

Ask your doctor for instructions and the risks about taking this medicine if you are also taking:

  • propranolol (see section 3)
  • SSRIs such as sertraline, escitalopram oxalate, and fluoxetine
  • SNRIs such as venlafaxine, and duloxetine for depression

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.

Taking this medicine with food and drink

This medicine can take longer to work if it is taken after food. Although it is better to take it on an empty stomach, you can still take it if you have eaten.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

It is not known whether rizatriptan is harmful to an unborn baby when taken by a pregnant woman.

Breast-feeding should be avoided for 24 hours after treatment.

Driving and using machines

You may feel sleepy or dizzy while taking rizatriptan. If this happens, do not drive or use any tools or machines.

3. How to take this medicine

Rizatriptan is used to treat migraine attacks. Take this medicine as soon as possible after your migraine headache has started. Do not use it to prevent an attack.

Always take this medicine exactly as your doctor has told you.

Check with your doctor or pharmacist if you are not sure.

The recommended dose is 10mg.

If you are currently taking propranolol or have kidney or liver problems, you should use the 5mg dose of rizatriptan. You should leave at least 2 hours between taking propranolol and rizatriptan up to a maximum of 2 doses in a 24-hour period.

Rizatriptan tablets should be taken by mouth and swallowed whole with liquid. The tablets are not intended to be divided.

If migraine returns within 24 hours

In some patients, migraine symptoms can return within a 24-hour period. If your migraine does return you can take an additional dose of this medicine. You should always wait at least 2 hours between doses.

If after 2 hours you still have a migraine

If you do not respond to the first dose of this medicine during an attack, you should not take a second dose of rizatriptan for treatment of the same attack. It is still likely, however, that you will respond to this medicine during the next attack.

Do not take more than 2 doses of rizatriptan in a 24-hour period. You should always wait at least 2 hours between doses.

If your condition worsens, seek medical attention.

Use in children and adolescents

The use of this medicine in children under 18 years of age is not recommended.

Use in patients older than 65 years

There have been no full studies to look at how safe and effective this medicine is amongst patients older than 65 years.

If you take more of this medicine than you should

If you take more rizatriptan than you should, talk to your doctor or pharmacist straight away. Take the medicine pack with you.

Signs of overdose can include dizziness, drowsiness, vomiting, fainting and slow heart rate.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine.

During studies in adults, the most common side effects reported were dizziness, sleepiness and tiredness.

Tell your doctor right away if you have symptoms of allergic reactions, serotonin syndrome, heart attack or stroke (see the list below).

In addition, tell your doctor if you experience any symptoms that suggest an allergic reaction (such as a rash or itching) after taking this medicine.

Common: may affect up to 1 in 10 people

  • tingling (paraesthesia), headache, decreased sensitivity of skin (hypoaesthesia), decreased mental sharpness, insomnia
  • fast or irregular heartbeat (palpitation)
  • flushing (redness of the face lasting a short time)
  • throat discomfort
  • feeling sick (nausea), dry mouth, vomiting, diarrhoea, indigestion (dyspepsia)
  • feeling of heaviness in parts of the body, neck pain, stiffness
  • pain in abdomen or chest

Uncommon: may affect up to 1 in 100 people

  • bad taste in your mouth
  • unsteadiness when walking (ataxia), dizziness (vertigo), blurred vision, tremor, fainting (syncope)
  • confusion, nervousness
  • high blood pressure (hypertension), thirst, hot flushes, sweating
  • rash, itching and lumpy rash (hives), swelling of face, lips, tongue and/or throat which may cause difficulty breathing and/or swallowing (angioedema), difficulty breathing (dyspnoea)
  • feeling of tightness in parts of the body, muscle weakness
  • changes in rhythm or rate of the heartbeat (arrhythmia), abnormalities of the electrocardiogram (a test that records the electrical activity of your heart), very fast heartbeat (tachycardia)
  • facial pain, muscle pain

Rare: may affect up to 1 in 1000 people

  • wheezing
  • allergic reaction (hypersensitivity), sudden life-threatening allergic reaction (anaphylaxis)
  • stroke (this generally occurs in patients with risk factors for heart and blood vessel disease (high blood pressure, diabetes, smoking, use of nicotine substitution, family history of heart disease or stroke, men over 40 years of age, postmenopausal women, particular problem with the way your heart beats [bundle branch block])
  • slow heartbeat (bradycardia)

Not known: frequency cannot be estimated from the available data

  • heart attack, spasm of blood vessels of the heart. These generally occur in patients with risk factors for heart and blood vessel disease (high blood pressure, diabetes, smoking, use of nicotine substitution, family history of heart disease or stroke, men over 40 years of age, post-menopausal women, particular problem with the way your heart beats [bundle branch block])
  • a syndrome called ‘serotonin syndrome’ that may cause side effects such as coma, unstable blood pressure, extremely high body temperature, lack of muscle co-ordination, agitation and hallucinations
  • severe shedding of the skin with or without fever (toxic epidermal necrolysis)
  • seizure (convulsions/fits)
  • spasm of blood vessels of the extremities including coldness and numbness of the hands or feet
  • spasm of the blood vessels of the colon (large bowel), which can cause abdominal pain

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme (website: www.mhra.gov.uk/yellowcard) or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store this medicine

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.

Do not store above 30°C.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information
What this medicine contains

The active substance is rizatriptan.

Each 5mg tablet contains 7.265mg of rizatriptan benzoate equivalent to 5mg of rizatriptan.

Each 10mg tablet contains 14.53mg of rizatriptan benzoate equivalent to 10mg of rizatriptan.

The other ingredients are: microcrystalline cellulose, maize starch, pregelatinised, starch (maize), iron oxide red (E172), magnesium stearate.

What this medicine looks like and contents of the pack

5mg tablets are pale pink, round and biconvex with dimensions 6.0±0.1mm and 3.0±0.2mm in thickness.

10mg tablets are pale pink, round and biconvex, with a score line in one side and dimensions 8.0±0.1mm and 3.5 ±0.2mm in thickness.

Pack sizes: 2, 3, 6, 12 or 18 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

Aspire Pharma Ltd
Unit 4
Rotherbrook Court
Bedford Road
Petersfield
Hampshire
GU32 3QG
United Kingdom

Manufacturer:

Pharmathen S.A.
6 Dervenakion str
15351 Pallini Attiki
Greece

or

Pharmathen International S.A
Industrial Park Sapes
Rodopi Prefecture
Block No 5
Rodopi 69300
Greece

This leaflet was last revised in 11/2022

1010072 - P7.3

Aspire Pharma Ltd
Company image
Address
4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, UK
Telephone
+44 (0)1730 231148
Medical Information Direct Line
+44 (0)1730 231148
Customer Care direct line
+44 (0)1730 231148